Stryker Corp (SYK)
384.85
-5.29
(-1.36%)
USD |
NYSE |
Nov 22, 16:00
385.01
+0.16
(+0.04%)
Pre-Market: 20:00
Stryker Revenue (Quarterly): 5.494B for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.494B |
| June 30, 2024 | 5.422B |
| March 31, 2024 | 5.243B |
| December 31, 2023 | 5.815B |
| September 30, 2023 | 4.909B |
| June 30, 2023 | 4.996B |
| March 31, 2023 | 4.778B |
| December 31, 2022 | 5.202B |
| September 30, 2022 | 4.479B |
| June 30, 2022 | 4.493B |
| March 31, 2022 | 4.275B |
| December 31, 2021 | 4.701B |
| September 30, 2021 | 4.16B |
| June 30, 2021 | 4.294B |
| March 31, 2021 | 3.953B |
| December 31, 2020 | 4.262B |
| September 30, 2020 | 3.737B |
| June 30, 2020 | 2.764B |
| March 31, 2020 | 3.588B |
| December 31, 2019 | 4.131B |
| September 30, 2019 | 3.587B |
| June 30, 2019 | 3.65B |
| March 31, 2019 | 3.516B |
| December 31, 2018 | 3.796B |
| September 30, 2018 | 3.242B |
| Date | Value |
|---|---|
| June 30, 2018 | 3.322B |
| March 31, 2018 | 3.241B |
| December 31, 2017 | 3.471B |
| September 30, 2017 | 3.006B |
| June 30, 2017 | 3.012B |
| March 31, 2017 | 2.955B |
| December 31, 2016 | 3.157B |
| September 30, 2016 | 2.833B |
| June 30, 2016 | 2.84B |
| March 31, 2016 | 2.495B |
| December 31, 2015 | 2.715B |
| September 30, 2015 | 2.42B |
| June 30, 2015 | 2.432B |
| March 31, 2015 | 2.379B |
| December 31, 2014 | 2.618B |
| September 30, 2014 | 2.389B |
| June 30, 2014 | 2.363B |
| March 31, 2014 | 2.305B |
| December 31, 2013 | 2.468B |
| September 30, 2013 | 2.151B |
| June 30, 2013 | 2.212B |
| March 31, 2013 | 2.19B |
| December 31, 2012 | 2.338B |
| September 30, 2012 | 2.052B |
| June 30, 2012 | 2.106B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.764B
Minimum
Jun 2020
5.815B
Maximum
Dec 2023
4.535B
Average
4.486B
Median
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| Globus Medical Inc | 625.70M |
| Zimmer Biomet Holdings Inc | 1.824B |
| Baxter International Inc | 2.699B |
| Treace Medical Concepts Inc | 45.09M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 834.00M |
| Total Expenses (Quarterly) | 4.409B |
| EPS Diluted (Quarterly) | 2.16 |
| Enterprise Value | 157.51B |
| Gross Profit Margin (Quarterly) | 64.02% |
| Profit Margin (Quarterly) | 15.18% |
| Earnings Yield | 2.42% |
| Operating Earnings Yield | 2.96% |
| Normalized Earnings Yield | 2.424 |